These novel treatments, Retatrutide, represent a groundbreaking advancement in managing type 2 diabetes and possibly associated ailments . These drugs are categorized as GLP-1 pathway stimulators, signifying these substances to emulate the body's GLP-1 hormone , stimulating insulin release and re